Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 38
Filter
1.
Gastroenterology ; 165(4): 986-998.e11, 2023 10.
Article in English | MEDLINE | ID: mdl-37429363

ABSTRACT

BACKGROUND & AIMS: Acute diarrheal diseases are the second most common cause of infant mortality in developing countries. This is contributed to by lack of effective drug therapy that shortens the duration or lessens the volume of diarrhea. The epithelial brush border sodium (Na+)/hydrogen (H+) exchanger 3 (NHE3) accounts for a major component of intestinal Na+ absorption and is inhibited in most diarrheas. Because increased intestinal Na+ absorption can rehydrate patients with diarrhea, NHE3 has been suggested as a potential druggable target for drug therapy for diarrhea. METHODS: A peptide (sodium-hydrogen exchanger 3 stimulatory peptide [N3SP]) was synthesized to mimic the part of the NHE3 C-terminus that forms a multiprotein complex that inhibits NHE3 activity. The effect of N3SP on NHE3 activity was evaluated in NHE3-transfected fibroblasts null for other plasma membrane NHEs, a human colon cancer cell line that models intestinal absorptive enterocytes (Caco-2/BBe), human enteroids, and mouse intestine in vitro and in vivo. N3SP was delivered into cells via a hydrophobic fluorescent maleimide or nanoparticles. RESULTS: N3SP uptake stimulated NHE3 activity at nmol/L concentrations under basal conditions and partially reversed the reduced NHE3 activity caused by elevated adenosine 3',5'-cyclic monophosphate, guanosine 3',5'-cyclic monophosphate, and Ca2+ in cell lines and in in vitro mouse intestine. N3SP also stimulated intestinal fluid absorption in the mouse small intestine in vivo and prevented cholera toxin-, Escherichia coli heat-stable enterotoxin-, and cluster of differentiation 3 inflammation-induced fluid secretion in a live mouse intestinal loop model. CONCLUSIONS: These findings suggest pharmacologic stimulation of NHE3 activity as an efficacious approach for the treatment of moderate/severe diarrheal diseases.


Subject(s)
Enterotoxins , Sodium-Hydrogen Exchangers , Mice , Animals , Humans , Sodium-Hydrogen Exchanger 3/metabolism , Enterotoxins/pharmacology , Enterotoxins/metabolism , Caco-2 Cells , Sodium-Hydrogen Exchangers/metabolism , Enterocytes/metabolism , Sodium/metabolism , Diarrhea/drug therapy , Diarrhea/prevention & control , Diarrhea/chemically induced , Peptides/adverse effects , Microvilli/metabolism
2.
Front Physiol ; 13: 892112, 2022.
Article in English | MEDLINE | ID: mdl-35928564

ABSTRACT

Use of human enteroids studied in the undifferentiated and differentiated state that mimic the intestinal crypt and villus, respectively, has allowed studies of multiple enterocyte populations, including a large population of enterocytes that are transitioning from the crypt to the villus. This population expresses NHE3, DRA, and CFTR, representing a combination of Na absorptive and anion secretory functions. In this cell population, these three transporters physically interact, which affects their baseline and regulated activities. A study of this cell population and differentiated Caco-2 cells transduced with NHE3 and endogenously expressing DRA and CFTR has allowed an understanding of previous studies in which cAMP seemed to stimulate and inhibit DRA at the same time. Understanding the contributions of these cells to overall intestinal transport function as part of the fasting and post-prandial state and their contribution to the pathophysiology of diarrheal diseases and some conditions with constipation will allow new approaches to drug development.

3.
Cell Physiol Biochem ; 56(1): 39-49, 2022 Jan 26.
Article in English | MEDLINE | ID: mdl-35076190

ABSTRACT

BACKGROUND/AIMS: NHE3 (Na+/H+ exchanger3) and SLC26A3 (Cl-/HCO3- exchanger, DRA) are the major components of the intestinal neutral NaCl absorptive process and based on the intestinal segment, contribute to HCO3- absorption and HCO3- secretion. NHE3 and DRA are highly regulated by changes in second messengers, cAMP, cGMP and Ca2+. Precise and convenient measurement of exchanger activity is necessary to allow rapid study of physiologic and pharmacologic functions. Some epithelial cells are difficult to load with AM ester dyes and loading may not be uniform. METHODS: The use of a genetically modified fluorescent protein, mOrange2 was explored as an intracellular pH sensor protein to measure exchange activity of NHE3 and DRA. The model used was FRT cells stably expressing NHE3 or DRA with intracellular pH measured by changes of mOrange2 fluorescence intensity. Intracellular pH was monitored using a) Isolated single clones of FRT/mOrange2/HA-NHE3 cells studied in a confocal microscope with time-lapse live cell imaging under basal conditions and when NHE3 was inhibited by exposure to forskolin and stimulated by dexamethasone, b) coverslip grown FRT/mOrange2 cells expressing NHE3 or DRA using a computerized fluorometer with a perfused cuvette with standardization of the mOrange2 absorption and emission signal using K+/Nigericin as an internal standard in each experiment. RESULTS: A similar rate of intracellular alkalization by Na+ addition in cells expressing NHE3 and by Cl- removal in cells expressing DRA was found in mOrange2 expressing cells compared to the same cells loaded with BCECF-AM,both using the same pH calibration with K+/Nigericin. Using mOrange2 as the pH sensor, NHE3 basal activity was quantitated and shown to be inhibited by forskolin and stimulated by dexamethasone, and DRA was oppositely shown to be stimulated by forskolin, responses similar to results found using BCECF-AM. CONCLUSION: This study demonstrates that mOrange2 protein can be an effective alternate to BCECF-AM in measuring intracellular pH (preferred setting Ex520nm, Em 563nm) as affected by NHE3 and DRA activity, with the advantage, compared to AM ester dyes, that genetic expression can provide uniform expression of the pH sensor.


Subject(s)
Antiporters/metabolism , Fluoresceins/pharmacology , Luminescent Proteins/metabolism , Sodium-Hydrogen Exchanger 3/metabolism , Sulfate Transporters/metabolism , Animals , Antiporters/genetics , Hydrogen-Ion Concentration , Luminescent Proteins/genetics , Rats , Rats, Inbred F344 , Sodium-Hydrogen Exchanger 3/genetics , Sulfate Transporters/genetics
4.
Cancer Treat Res ; 180: 51-94, 2020.
Article in English | MEDLINE | ID: mdl-32215866

ABSTRACT

The premise of this book is the importance of the tumor microenvironment (TME). Until recently, most research on and clinical attention to cancer biology, diagnosis, and prognosis were focused on the malignant (or premalignant) cellular compartment that could be readily appreciated using standard morphology-based imaging.


Subject(s)
Neoplasms/diagnostic imaging , Tumor Microenvironment , Humans
5.
PLoS One ; 15(2): e0228112, 2020.
Article in English | MEDLINE | ID: mdl-32040512

ABSTRACT

Neoantigens can be predicted and in some cases identified using the data obtained from the whole exome sequencing and transcriptome sequencing of tumor cells. These sequencing data can be coupled with single-cell RNA sequencing for the direct interrogation of the transcriptome, surfaceome, and pairing of αß T-cell receptors (TCRαß) from hundreds of single T cells. Using these 2 large datasets, we established a platform for identifying antigens recognized by TCRαßs obtained from single T cells. Our approach is based on the rapid expression of cloned TCRαß genes as Sleeping Beauty transposons and the determination of the introduced TCRαßs' antigen specificity and avidity using a reporter cell line. The platform enables the very rapid identification of tumor-reactive TCRs for the bioengineering of T cells with redirected specificity.


Subject(s)
Cell Engineering/methods , Cloning, Molecular/methods , Receptors, Antigen, T-Cell/genetics , T-Lymphocytes/cytology , T-Lymphocytes/metabolism , Gene Expression , Gene Library , Genes, MHC Class I/genetics , Genes, MHC Class II/genetics , HEK293 Cells , Humans , Kinetics , Receptors, Antigen, T-Cell, alpha-beta/genetics
6.
Am J Physiol Cell Physiol ; 317(4): C737-C748, 2019 10 01.
Article in English | MEDLINE | ID: mdl-31365292

ABSTRACT

Enterotoxigenic Escherichia coli (ETEC) is a leading cause of childhood death from diarrhea and the leading cause of Traveler's diarrhea. E. coli heat-stable enterotoxin (ST) is a major virulence factor of ETEC and inhibits the brush border Na/H exchanger NHE3 in producing diarrhea. NHE3 regulation involves multiprotein signaling complexes that form on its COOH terminus. In this study, the hypothesis was tested that ST signals via members of the Na/H exchanger regulatory factor (NHERF) family of scaffolding proteins, NHERF2, which had been previously shown to have a role, and now with concentration on a role for NHERF3. Two models were used: mouse small intestine and Caco-2/BBe cells. In both models, ST rapidly increased intracellular cGMP, inhibited NHE3 activity, and caused a quantitatively similar decrease in apical expression of NHE3. The transport effects were NHERF3 and NHERF2 dependent. Also, mutation of the COOH-terminal amino acids of NHERF3 supported that NHERF3-NHERF2 heterodimerization was likely to account for this dual dependence. The ST increase in cGMP in both models was partially dependent on NHERF3. The intracellular signaling pathways by which ST-cGMP inhibits NHE3 were different in mouse jejunum (activation of cGMP kinase II, cGKII) and Caco-2 cells, which do not express cGKII (elevation of intracellular Ca2+ concentration [Ca2+]i). The ST elevation of [Ca2+]i was from intracellular stores and was dependent on NHERF3-NHERF2. This study shows that intracellular signaling in the same diarrheal model in multiple cell types may be different; this has implications for therapeutic strategies, which often assume that models have similar signaling mechanisms.


Subject(s)
Bacterial Toxins/pharmacology , Enterotoxins/pharmacology , Escherichia coli Proteins/pharmacology , Membrane Proteins/drug effects , Sodium-Hydrogen Exchanger 3/drug effects , Animals , Caco-2 Cells , Cyclic GMP/metabolism , Diarrhea/chemically induced , Escherichia coli/drug effects , Humans , Mice, Transgenic
7.
Cancer Lett ; 436: 109-118, 2018 11 01.
Article in English | MEDLINE | ID: mdl-30144514

ABSTRACT

Primary organoid cultures generated from patient biopsies comprise a novel improved platform for disease modeling, being genetically stable and closely recapitulating in vivo scenarios. Barrett esophagus (BE) is the major risk factor for esophageal adenocarcinoma. There has been a dearth of long-term in vitro expansion models of BE neoplastic transformation. We generated a long-term virus-free organoid expansion model of BE neoplasia from patient biopsies. Both wild-type and paired APC-knockout (APCKO) BE organoids genome-edited by CRISPR-Cas9 showed characteristic goblet cell differentiation. Autonomous Wnt activation was confirmed in APCKO organoids by overexpression of Wnt target genes and nuclear-translocated ß-catenin expression after withdrawal of Wnt-3A and R-spondin-1. Wnt-activated organoids demonstrated histologic atypia, higher proliferative and replicative activity, reduced apoptosis, and prolonged culturability. Wnt-activated organoids also showed sustained protrusive migration ability accompanied by disrupted basement membrane reorganization and integrity. This CRISPR-Cas9 editing human-derived organoid model recapitulates the critical role of aberrant Wnt/ß-catenin signaling activation in BE neoplastic transformation. This system can be used to study other 'driver' pathway alterations in BE-associated neoplasia, avoiding signaling noise present in immortalized or cancer-derived cell lines.


Subject(s)
Barrett Esophagus/metabolism , CRISPR-Cas Systems , Cell Transformation, Neoplastic/genetics , Gene Editing/methods , Wnt Signaling Pathway/genetics , beta Catenin/genetics , Adenomatous Polyposis Coli Protein/genetics , Adenomatous Polyposis Coli Protein/metabolism , Apoptosis/genetics , Barrett Esophagus/pathology , Cell Differentiation/genetics , Cell Movement/genetics , Cell Proliferation/genetics , Gene Knockout Techniques , Humans , Models, Genetic , Organoids/metabolism , Organoids/pathology
8.
Curr Protoc Hum Genet ; 94: 4.4.1-4.4.89, 2017 07 11.
Article in English | MEDLINE | ID: mdl-28696557

ABSTRACT

This unit provides an overview of light microscopy, including objectives, light sources, filters, film, and color photography for fluorescence microscopy and fluorescence in situ hybridization (FISH). We believe there are excellent opportunities for cytogeneticists, pathologists, and other biomedical readers, to take advantage of specimen optical clearing techniques and expansion microscopy-we briefly point to these new opportunities. © 2017 by John Wiley & Sons, Inc.


Subject(s)
Microscopy/instrumentation , Microscopy/methods , Animals , Color , Cytogenetics , Humans , In Situ Hybridization, Fluorescence , Microscopy, Fluorescence , Pathology , Photography
9.
PLoS One ; 11(8): e0159477, 2016.
Article in English | MEDLINE | ID: mdl-27548616

ABSTRACT

Adoptive immunotherapy infusing T cells with engineered specificity for CD19 expressed on B- cell malignancies is generating enthusiasm to extend this approach to other hematological malignancies, such as acute myelogenous leukemia (AML). CD123, or interleukin 3 receptor alpha, is overexpressed on most AML and some lymphoid malignancies, such as acute lymphocytic leukemia (ALL), and has been an effective target for T cells expressing chimeric antigen receptors (CARs). The prototypical CAR encodes a VH and VL from one monoclonal antibody (mAb), coupled to a transmembrane domain and one or more cytoplasmic signaling domains. Previous studies showed that treatment of an experimental AML model with CD123-specific CAR T cells was therapeutic, but at the cost of impaired myelopoiesis, highlighting the need for systems to define the antigen threshold for CAR recognition. Here, we show that CARs can be engineered using VH and VL chains derived from different CD123-specific mAbs to generate a panel of CAR+ T cells. While all CARs exhibited specificity to CD123, one VH and VL combination had reduced lysis of normal hematopoietic stem cells. This CAR's in vivo anti-tumor activity was similar whether signaling occurred via chimeric CD28 or CD137, prolonging survival in both AML and ALL models. Co-expression of inducible caspase 9 eliminated CAR+ T cells. These data help support the use of CD123-specific CARs for treatment of CD123+ hematologic malignancies.


Subject(s)
Genetic Engineering/methods , Immunotherapy, Adoptive/methods , Interleukin-3 Receptor alpha Subunit/immunology , Leukemia, Myeloid, Acute/therapy , Precursor Cell Lymphoblastic Leukemia-Lymphoma/therapy , Recombinant Fusion Proteins/immunology , T-Lymphocytes/transplantation , Animals , B-Lymphocytes/immunology , B-Lymphocytes/pathology , CD28 Antigens/genetics , CD28 Antigens/immunology , Caspase 9/genetics , Caspase 9/immunology , Cytotoxicity, Immunologic , Disease Models, Animal , Gene Expression , Hematopoietic Stem Cells/immunology , Hematopoietic Stem Cells/pathology , Humans , Interleukin-3 Receptor alpha Subunit/genetics , Leukemia, Myeloid, Acute/genetics , Leukemia, Myeloid, Acute/immunology , Leukemia, Myeloid, Acute/pathology , Mice , Mice, Inbred NOD , Mice, SCID , Molecular Targeted Therapy , Plasmids , Precursor Cell Lymphoblastic Leukemia-Lymphoma/genetics , Precursor Cell Lymphoblastic Leukemia-Lymphoma/immunology , Precursor Cell Lymphoblastic Leukemia-Lymphoma/pathology , Recombinant Fusion Proteins/genetics , Single-Domain Antibodies/genetics , T-Lymphocytes/cytology , T-Lymphocytes/immunology , Transfection , Tumor Necrosis Factor Receptor Superfamily, Member 9/genetics , Tumor Necrosis Factor Receptor Superfamily, Member 9/immunology
10.
J Biomol Tech ; 27(3): 90-7, 2016 09.
Article in English | MEDLINE | ID: mdl-27182204

ABSTRACT

Standards in quantitative fluorescent imaging are vaguely recognized and receive insufficient discussion. A common best practice is to acquire images at Nyquist rate, where highest signal frequency is assumed to be the highest obtainable resolution of the imaging system. However, this particular standard is set to insure that all obtainable information is being collected. The objective of the current study was to demonstrate that for quantification purposes, these correctly set acquisition rates can be redundant; instead, linear size of the objects of interest can be used to calculate sufficient information density in the image. We describe optimized image acquisition parameters and unbiased methods for processing and quantification of medium-size cellular structures. Sections of rabbit aortas were immunohistochemically stained to identify and quantify sympathetic varicosities, >2 µm in diameter. Images were processed to reduce background noise and segment objects using free, open-access software. Calculations of the optimal sampling rate for the experiment were based on the size of the objects of interest. The effect of differing sampling rates and processing techniques on object quantification was demonstrated. Oversampling led to a substantial increase in file size, whereas undersampling hindered reliable quantification. Quantification of raw and incorrectly processed images generated false structures, misrepresenting the underlying data. The current study emphasizes the importance of defining image-acquisition parameters based on the structure(s) of interest. The proposed postacquisition processing steps effectively removed background and noise, allowed for reliable quantification, and eliminated user bias. This customizable, reliable method for background subtraction and structure quantification provides a reproducible tool for researchers across biologic disciplines.


Subject(s)
Tyrosine 3-Monooxygenase/metabolism , Animals , Fluorescent Antibody Technique, Indirect , Microscopy, Fluorescence , Rabbits , Signal-To-Noise Ratio , Sympathetic Nervous System/cytology , Sympathetic Nervous System/enzymology
11.
Blood ; 125(4): 649-57, 2015 Jan 22.
Article in English | MEDLINE | ID: mdl-25381061

ABSTRACT

Human germinal center-associated lymphoma (HGAL) is specifically expressed only in germinal center (GC) B lymphocytes and GC-derived lymphomas. HGAL protein decreases lymphocyte motility by inhibiting the ability of myosin to translocate actin via direct interaction with F-actin and myosin II and by activating RhoA signaling via direct interactions with RhoA-specific guanine nucleotide exchange factors. HGAL protein also regulates B-cell receptor (BCR) signaling by directly binding to and enhancing Syk kinase activity and activation of its downstream effectors. Herein we demonstrate that HGAL protein can be myristoylated and palmitoylated and that these modifications localize HGAL to cellular membrane raft microdomains with distinct consequences for BCR signaling and chemoattractant-induced cell mobility. In BCR signaling, raft localization of HGAL facilitates interaction with Syk and modulation of the BCR activation and signaling, which induces HGAL phosphorylation and redistribution from lipid raft to bulk membrane and cytoplasm, followed by degradation. In contrast, HGAL myristoylation and palmitoylation avert its inhibitory effects on chemoattractant-induced cell motility. These findings further elucidate the growing and complex role of HGAL in B-cell biology and suggest that membrane-bound and cytoplasmic HGAL protein differently regulates distinct biological processes.


Subject(s)
B-Lymphocytes/metabolism , Membrane Microdomains/metabolism , Neoplasm Proteins/metabolism , Receptors, Antigen, B-Cell/metabolism , Signal Transduction/physiology , Actins/genetics , Actins/immunology , Actins/metabolism , B-Lymphocytes/cytology , B-Lymphocytes/immunology , Cell Movement/genetics , Cell Movement/immunology , Chemotactic Factors/genetics , Chemotactic Factors/immunology , Chemotactic Factors/metabolism , Cytoplasm/genetics , Cytoplasm/immunology , Cytoplasm/metabolism , HeLa Cells , Humans , Intracellular Signaling Peptides and Proteins/genetics , Intracellular Signaling Peptides and Proteins/immunology , Intracellular Signaling Peptides and Proteins/metabolism , Lipoylation/genetics , Lipoylation/immunology , Membrane Microdomains/genetics , Membrane Microdomains/immunology , Microfilament Proteins , Myosin Type II/genetics , Myosin Type II/immunology , Myosin Type II/metabolism , Neoplasm Proteins/genetics , Neoplasm Proteins/immunology , Protein Transport/physiology , Protein-Tyrosine Kinases/genetics , Protein-Tyrosine Kinases/immunology , Protein-Tyrosine Kinases/metabolism , Proteolysis , Receptors, Antigen, B-Cell/genetics , Receptors, Antigen, B-Cell/immunology , Syk Kinase , rho GTP-Binding Proteins/genetics , rho GTP-Binding Proteins/immunology , rho GTP-Binding Proteins/metabolism , rhoA GTP-Binding Protein
12.
J Clin Invest ; 124(2): 859-70, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24463450

ABSTRACT

Accurate classification is essential for understanding the pathophysiology of a disease and can inform therapeutic choices. For hematopoietic malignancies, a classification scheme based on the phenotypic similarity between tumor cells and normal cells has been successfully used to define tumor subtypes; however, use of normal cell types as a reference by which to classify solid tumors has not been widely emulated, in part due to more limited understanding of epithelial cell differentiation compared with hematopoiesis. To provide a better definition of the subtypes of epithelial cells comprising the breast epithelium, we performed a systematic analysis of a large set of breast epithelial markers in more than 15,000 normal breast cells, which identified 11 differentiation states for normal luminal cells. We then applied information from this analysis to classify human breast tumors based on normal cell types into 4 major subtypes, HR0-HR3, which were differentiated by vitamin D, androgen, and estrogen hormone receptor (HR) expression. Examination of 3,157 human breast tumors revealed that these HR subtypes were distinct from the current classification scheme, which is based on estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2. Patient outcomes were best when tumors expressed all 3 hormone receptors (subtype HR3) and worst when they expressed none of the receptors (subtype HR0). Together, these data provide an ontological classification scheme associated with patient survival differences and provides actionable insights for treating breast tumors.


Subject(s)
Breast Neoplasms/classification , Breast Neoplasms/metabolism , Breast Neoplasms/pathology , Breast/metabolism , Breast/pathology , Adolescent , Adult , Antigens, CD/metabolism , Biomarkers , Breast Neoplasms/therapy , Cell Differentiation , Cell Line, Tumor , Cell Proliferation , Cohort Studies , Female , Gene Expression Profiling , Gene Expression Regulation , Hematopoiesis , Humans , Immunohistochemistry , Intermediate Filaments/metabolism , Middle Aged , Phenotype , Prospective Studies , Receptors, Androgen/metabolism , Receptors, Calcitriol/metabolism , Receptors, Estrogen/metabolism , Treatment Outcome , Young Adult
13.
Methods Mol Biol ; 1075: 149-75, 2014.
Article in English | MEDLINE | ID: mdl-24052350

ABSTRACT

Blood vessels are critical to normal mammalian development, tissue repair, and growth and treatment of cancer. Mouse research models enable mechanistic studies of blood vessels. We detail how to perfuse mice with fluorescent tomato lectin or the lipophilic fluorophore DiI. We provide details on how to image fluorescently labeled blood vessels.


Subject(s)
Blood Vessels/ultrastructure , Microscopy, Confocal/methods , Neoplasms/pathology , Neovascularization, Pathologic/pathology , Animals , Blood Vessels/pathology , Disease Models, Animal , Fluorescent Dyes , Green Fluorescent Proteins , Humans , Mice
14.
Stud Health Technol Inform ; 185: 43-75, 2013.
Article in English | MEDLINE | ID: mdl-23542931

ABSTRACT

Spectral imaging methods are attracting increased interest from researchers and practitioners in basic science, preclinical and clinical arenas. A combination of better labeling reagents and better optics creates opportunities to detect and measure multiple parameters at the molecular and cellular level. These tools can provide valuable insights into the basic mechanisms of life, and yield diagnostic and prognostic information for clinical applications. There are many multispectral technologies available, each with its own advantages and limitations. This chapter will present an overview of the rationale for spectral imaging, and discuss the hardware, software and sample labeling strategies that can optimize its usefulness in clinical settings.


Subject(s)
Cell Tracking/instrumentation , Cytodiagnosis/instrumentation , Image Interpretation, Computer-Assisted/instrumentation , Molecular Imaging/instrumentation , Spectrum Analysis/instrumentation , Animals , Equipment Design , Humans , Image Interpretation, Computer-Assisted/methods , Research Design
15.
Nat Commun ; 4: 1338, 2013.
Article in English | MEDLINE | ID: mdl-23299888

ABSTRACT

The human germinal centre-associated lymphoma gene is specifically expressed in germinal centre B-lymphocytes and germinal centre-derived B-cell lymphomas, but its function is largely unknown. Here we demonstrate that human germinal centre-associated lymphoma directly binds to Syk in B cells, increases its kinase activity on B-cell receptor stimulation and leads to enhanced activation of Syk downstream effectors. To further investigate these findings in vivo, human germinal centre-associated lymphoma transgenic mice were generated. Starting from 12 months of age these mice developed polyclonal B-cell lymphoid hyperplasia, hypergammaglobulinemia and systemic reactive amyloid A (AA) amyloidosis, leading to shortened survival. The lymphoid hyperplasia in the human germinal centre-associated lymphoma transgenic mice are likely attributable to enhanced B-cell receptor signalling as shown by increased Syk phosphorylation, ex vivo B-cell proliferation and increased RhoA activation. Overall, our study shows for the first time that the germinal centre protein human germinal centre-associated lymphoma regulates B-cell receptor signalling in B-lymphocytes which, without appropriate control, may lead to B-cell lymphoproliferation.


Subject(s)
Amyloidosis/pathology , Germinal Center/metabolism , Intracellular Signaling Peptides and Proteins/metabolism , Lymphoma, B-Cell/enzymology , Lymphoma, B-Cell/pathology , Neoplasm Proteins/metabolism , Protein-Tyrosine Kinases/metabolism , Receptors, Antigen, B-Cell/metabolism , Amino Acid Sequence , Amyloidosis/complications , Animals , Antigens, Ly/metabolism , Cell Extracts , Disease Models, Animal , Enzyme Activation , Germinal Center/pathology , Humans , Hypergammaglobulinemia/pathology , Hyperplasia , Intracellular Space/metabolism , Kaplan-Meier Estimate , Lymphoma, B-Cell/complications , Membrane Proteins/metabolism , Mice , Microfilament Proteins , Molecular Sequence Data , Protein Binding , RNA, Small Interfering/metabolism , Serum Amyloid A Protein/chemistry , Serum Amyloid A Protein/metabolism , Signal Transduction , Spleen/metabolism , Spleen/pathology , Syk Kinase , Transcriptome/genetics , rhoA GTP-Binding Protein/metabolism
17.
Anal Cell Pathol (Amst) ; 35(5-6): 339-61, 2012.
Article in English | MEDLINE | ID: mdl-22475632

ABSTRACT

Spectral imaging methods are attracting increased interest from researchers and practitioners in basic science, pre-clinical and clinical arenas. A combination of better labeling reagents and better optics creates opportunities to detect and measure multiple parameters at the molecular and cellular level. These tools can provide valuable insights into the basic mechanisms of life, and yield diagnostic and prognostic information for clinical applications. There are many multispectral technologies available, each with its own advantages and limitations. This chapter will present an overview of the rationale for spectral imaging, and discuss the hardware, software and sample labeling strategies that can optimize its usefulness in clinical settings.


Subject(s)
Biomedical Research/methods , Diagnostic Imaging/methods , Pathology, Clinical/methods , Spectrum Analysis/methods , Animals , Humans , Microscopy , Phenotype
18.
Biotechniques ; 53(1)2012 Jul 01.
Article in English | MEDLINE | ID: mdl-26307258

ABSTRACT

The availability of transgenic disease backgrounds and the accessibility of molecular research reagents have contributed to make the mouse ischemic hindlimb the model of choice for many studies of angiogenesis, and to investigate new treatments for peripheral artery disease. A limitation of these models involves our inability to easily visualize the regenerated vascular architecture. Approaches such as micro-computed tomography and micro-angiography are expensive, technically demanding and not available to many laboratories. Here we describe a rapid and inexpensive adaptation of a vascular staining procedure for precise imaging of the mouse hindlimb vasculature. We introduced two technical modifications and an analytical extension to the original method including (i) pre-skinning of the muscle prior to fixation that preserves tissue integrity, (ii) mild pressure-desiccation subsequent to fixing that enhances resolution and image penetration, and (iii) reconstruction of confocal data into 3D images. The procedure provides resolution that is equivalent or superior to other approaches at a fraction of the cost, time and technology required.


Subject(s)
Carbocyanines/chemistry , Hindlimb/blood supply , Microscopy, Confocal/methods , Animals , Carbocyanines/administration & dosage , Hindlimb/injuries , Hindlimb/pathology , Imaging, Three-Dimensional , Ischemia/pathology , Mice , Mice, Inbred BALB C
19.
Lipids Health Dis ; 10: 198, 2011 Nov 03.
Article in English | MEDLINE | ID: mdl-22051061

ABSTRACT

BACKGROUND: Obesity is characterized by increased cell death and inflammatory reactions in the adipose tissue. Here, we explored pathophysiological alterations taking place in the adipose tissue in long-standing obesity. In the epididymal fat of C57BL/6 mice fed a high-fat diet for 20 weeks, the prevalence and distribution of dead adipocytes (crown-like structures), mast cells (toluidine blue, mMCP6), macrophages (F4/80), and apoptotic cells (cleaved caspase-3) were measured. Moreover, gene and/or protein expression of several adipocytokines (leptin, adiponectin, TNF-α, IL-10, IL-6, MCP-1), F4/80, mMCP6, cleaved caspase-3 were determined. RESULTS: We observed that the epididymal fat mass was lower in obese than in lean mice. In obese mice, the epididymal fat mass correlated inversely with body weight and liver mass. Dead adipocytes, mast cells, macrophages, and apoptotic cells were abundant in the epididymal fat of obese mice, especially in the rostral vs. caudal zone. Accordingly, mMCP6, F4/80, and cleaved caspase-3 gene and/or protein expression was increased. Conversely, adiponectin, leptin, IL-6, and MCP-1 gene expression levels were lower in the epididymal fat of obese than lean mice. Although TNF-α and IL-10 gene expression was higher in the epididymal fat of obese mice, their expression relative to F4/80 and mMCP6 expression were lower in the heavily infiltrated rostral than caudal zone. CONCLUSIONS: This study demonstrates that in mice with long-standing obesity diminished gene expression of several adipocytokines accompany apoptosis and reduced mass of the epididymal fat. Our findings suggest that this is due to both increased prevalence of dead adipocytes and altered immune cell activity. Differential distribution of metabolically challenged adipocytes is indicative of the presence of biologically diverse zones within the epididymal fat.


Subject(s)
Adiponectin/genetics , Adiposity , Leptin/genetics , Obesity/pathology , Adiponectin/metabolism , Adipose Tissue/pathology , Animals , Apoptosis , Chemokine CCL2/genetics , Chemokine CCL2/metabolism , Diet, High-Fat , Down-Regulation , Epididymis/enzymology , Epididymis/metabolism , Gene Expression , Interleukin-10/genetics , Interleukin-10/metabolism , Interleukin-6/genetics , Interleukin-6/metabolism , Leptin/metabolism , Liver/pathology , Macrophages/pathology , Male , Mast Cells/pathology , Mastocytosis , Mice , Mice, Inbred C57BL , Obesity/metabolism , Organ Size , Organ Specificity , Random Allocation , Tryptases/genetics , Tryptases/metabolism , Tumor Necrosis Factor-alpha/genetics , Tumor Necrosis Factor-alpha/metabolism
20.
J Immunol ; 185(11): 6985-98, 2010 Dec 01.
Article in English | MEDLINE | ID: mdl-20974981

ABSTRACT

Hepatitis C virus (HCV) infection is associated with the development of hepatocellular carcinoma and putatively also non-Hodgkin's B cell lymphoma. In this study, we demonstrated that PBMCs obtained from HCV-infected patients showed frequent chromosomal aberrations and that HCV infection of B cells in vitro induced enhanced chromosomal breaks and sister chromatid exchanges. HCV infection hypersensitized cells to ionizing radiation and bleomycin and inhibited nonhomologous end-joining repair. The viral core and nonstructural protein 3 proteins were shown to be responsible for the inhibition of DNA repair, mediated by NO and reactive oxygen species. Stable expression of core protein induced frequent chromosome translocations in cultured cells and in transgenic mice. HCV core protein binds to the NBS1 protein and inhibits the formation of the Mre11/NBS1/Rad50 complex, thereby affecting ATM activation and inhibiting DNA binding of repair enzymes. Taken together, these data indicate that HCV infection inhibits multiple DNA repair processes to potentiate chromosome instability in both monocytes and hepatocytes. These effects may explain the oncogenicity and immunological perturbation of HCV infection.


Subject(s)
Cell Cycle Proteins/antagonists & inhibitors , DNA Damage/immunology , DNA Repair/immunology , DNA-Binding Proteins/antagonists & inhibitors , Hepacivirus/immunology , Hepatocytes/immunology , Monocytes/immunology , Protein Serine-Threonine Kinases/antagonists & inhibitors , Reactive Nitrogen Species/physiology , Reactive Oxygen Species/pharmacology , Tumor Suppressor Proteins/antagonists & inhibitors , Acid Anhydride Hydrolases , Animals , Ataxia Telangiectasia/enzymology , Ataxia Telangiectasia Mutated Proteins , Cell Cycle Proteins/metabolism , Cell Line, Transformed , Cell Line, Tumor , Cells, Cultured , DNA Repair Enzymes/antagonists & inhibitors , DNA Repair Enzymes/physiology , DNA-Binding Proteins/metabolism , DNA-Binding Proteins/physiology , HEK293 Cells , Hep G2 Cells , Hepatocytes/metabolism , Hepatocytes/virology , Humans , MRE11 Homologue Protein , Mice , Mice, Transgenic , Monocytes/metabolism , Monocytes/virology , Nuclear Proteins/antagonists & inhibitors , Nuclear Proteins/metabolism , Protein Binding/immunology , Protein Serine-Threonine Kinases/metabolism , Signal Transduction/immunology , Tumor Suppressor Proteins/metabolism , Viral Core Proteins/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...